Diffusion Pharmaceuticals Inc. (DFFN) Stock Analysis
DELISTED 2023
What happened to Diffusion Pharmaceuticals Inc. (DFFN) stock?
Diffusion Pharmaceuticals Inc. (DFFN) no longer trades on public markets. It was delisted in August 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2023
- Last recorded price (historical):
- $4.40 (last quote on record before the August 2023 delisting; historical, not a current quote)
Market cap $8.98M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Diffusion Pharmaceuticals Inc. (DFFN). Diffusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing Trans Sodium Crocetinate (TSC), an investigational therapy designed to enhance oxygen diffusion into tissues.
Last analyzed: Jun 14, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Diffusion Pharmaceuticals Inc. (DFFN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy DFFN shares?
No. DFFN stopped trading on public markets in August 2023, so the shares are not available through a broker. Anything you see quoted for DFFN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DFFN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Diffusion Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.